Recent Updates
Recently added Catalysts
KURA Positive Sentiment

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit

Monday, November 25, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Kura Oncology, Inc. (NASDAQ: KURA) has announced its participation in the JMP Securities Hematology and Oncology Summit scheduled for December 2, 2024. CEO Troy Wilson will take part in a virtual fireside chat, aimed at discussing the company's approach to precision cancer medicines. The event represents an opportunity for Kura to engage with investors and industry stakeholders. A live audio webcast will be available on the company's website for those interested in attending.
Price reaction · baseline $10.8 (2024-11-22 close) · clean, no other KURA news in the window
day 0 close
+1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Kura Oncology is engaged in active participation at a significant industry summit.
  • Troy Wilson, their CEO, will be representing the company, enhancing visibility.
  • The event provides a platform to discuss advancements in hematology and oncology.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+116%
120-day peak, hindsight
Typical move
5.7%
average across 9 past catalysts
Cash runway
~25 mo
Low dilution risk
Lead asset
Tipifarnib
Phase 2 · Leukemia, Myelomonocytic, Chronic

Full Press Release Details

SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the upcoming JMP Securities Hematology and Oncology Summit. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at 2:00 p.m. ET / 11:00 a.m. PT on December 2, 2024.
A live audio webcast of the fireside chat will be available in the Investors section of Kura’s website at www.kuraoncology.com, with an archived replay available following the live event.
Executive Vice President, Investor Relations &

Frequently Asked Questions

What event will Kura Oncology participate in?

Kura Oncology will participate in the JMP Securities Hematology and Oncology Summit.

Who will represent Kura Oncology at the event?

Troy Wilson, Ph.D., J.D., will represent Kura Oncology.

When is the fireside chat scheduled?

The fireside chat is scheduled for December 2, 2024, at 2:00 p.m. ET.

Where can I watch the fireside chat?

The chat will be available on Kura's website in the Investors section.

Is there a replay available for the chat?

Yes, an archived replay will be available after the live event.

ShareAdd on Google
Tags: KURA Viatris Investor Conferences Healthcare Kura Oncology JMP Securities hematology oncology clinical-stage
Last updated: Nov 25, 2024

Biotech snapshot

Cash runway
$519M liquidity · $21M/mo burn
~25 mo
Low dilution risk
Lead asset
TipifarnibPhase 2
Leukemia, Myelomonocytic, Chronic →

Catalyst track record

+116%
best trade around KURA's most recent catalyst

Peak hindsight return over a 120-day window, across 9 tracked FDA/PDUFA catalysts for KURA.

See every catalyst's timing & PoA →